Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David F L Liew

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Internal Medicine Journal|June 4, 2026
Experience of Australian rheumatologists managing polymyalgia rheumatica: results from a national surveyJessica L Leung, Victor Yang, Jem V Ninan, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 25, 2020
Abnormalities at three musculoskeletal sites on whole-body positron emission tomography/computed tomography can diagnose polymyalgia rheumatica with high sensitivity and specificityClaire E Owen, Aurora M T Poon, Victor Yang, et al.
The Journal of Rheumatology|April 1, 2025
More Than Pain and Stiffness: Persistent Fatigue and Sleep Disturbance in Polymyalgia RheumaticaJessica L Leung, Belinda De Ross, Jenny Gianoudis, et al.
Rheumatology (Oxford, England)|September 7, 2022
COVID-19 vaccine hesitancy in inflammatory arthritis patients: serial surveys from a large longitudinal national Australian cohortChristopher McMaster, David F L Liew, Susan Lester, et al.
Rheumatology Advances in Practice|February 20, 2024
Characterising polymyalgia rheumatica on whole-body <sup>18</sup>F-FDG PET/CT: an atlasClaire E Owen, Aurora M T Poon, Bonnia Liu, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 6, 2022
COVID-19 therapeutics: Challenges and directions for the futurePhilip C Robinson, David F L Liew, Helen L Tanner, et al.
Rheumatology (Oxford, England)|February 12, 2025
Comparative safety of biologic and targeted synthetic disease-modifying anti-rheumatic drugs for cardiovascular outcomes in rheumatoid arthritisXavier Sendaydiego, Laura S Gold, Maureen Dubreuil, et al.
The Lancet. Rheumatology|July 6, 2024
Systemic lupus erythematosus in Aboriginal and Torres Strait Islander peoples in Australia: addressing disparities and barriers to optimising patient careLaura E Eades, Alberta Y Hoi, Ruaidhri Liddle, et al.
The Lancet. Rheumatology|June 22, 2026
Aligning approaches to rheumatoid arthritis drug development: a comparison of FDA and EMA guidanceAntonio Ciancio, Andrea Amati, Saviana Gandolfo, et al.
Rheumatology (Oxford, England)|November 10, 2017
Fusion of positron emission tomography/computed tomography with magnetic resonance imaging reveals hamstring peritendonitis in polymyalgia rheumaticaClaire E Owen, Aurora M T Poon, Sze Ting Lee, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Internal Medicine Journal|June 4, 2026
Experience of Australian rheumatologists managing polymyalgia rheumatica: results from a national surveyJessica L Leung, Victor Yang, Jem V Ninan, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 25, 2020
Abnormalities at three musculoskeletal sites on whole-body positron emission tomography/computed tomography can diagnose polymyalgia rheumatica with high sensitivity and specificityClaire E Owen, Aurora M T Poon, Victor Yang, et al.
The Journal of Rheumatology|April 1, 2025
More Than Pain and Stiffness: Persistent Fatigue and Sleep Disturbance in Polymyalgia RheumaticaJessica L Leung, Belinda De Ross, Jenny Gianoudis, et al.
Rheumatology (Oxford, England)|September 7, 2022
COVID-19 vaccine hesitancy in inflammatory arthritis patients: serial surveys from a large longitudinal national Australian cohortChristopher McMaster, David F L Liew, Susan Lester, et al.
Rheumatology Advances in Practice|February 20, 2024
Characterising polymyalgia rheumatica on whole-body <sup>18</sup>F-FDG PET/CT: an atlasClaire E Owen, Aurora M T Poon, Bonnia Liu, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 6, 2022
COVID-19 therapeutics: Challenges and directions for the futurePhilip C Robinson, David F L Liew, Helen L Tanner, et al.
Rheumatology (Oxford, England)|February 12, 2025
Comparative safety of biologic and targeted synthetic disease-modifying anti-rheumatic drugs for cardiovascular outcomes in rheumatoid arthritisXavier Sendaydiego, Laura S Gold, Maureen Dubreuil, et al.
The Lancet. Rheumatology|July 6, 2024
Systemic lupus erythematosus in Aboriginal and Torres Strait Islander peoples in Australia: addressing disparities and barriers to optimising patient careLaura E Eades, Alberta Y Hoi, Ruaidhri Liddle, et al.
The Lancet. Rheumatology|June 22, 2026
Aligning approaches to rheumatoid arthritis drug development: a comparison of FDA and EMA guidanceAntonio Ciancio, Andrea Amati, Saviana Gandolfo, et al.
Rheumatology (Oxford, England)|November 10, 2017
Fusion of positron emission tomography/computed tomography with magnetic resonance imaging reveals hamstring peritendonitis in polymyalgia rheumaticaClaire E Owen, Aurora M T Poon, Sze Ting Lee, et al.
Pageof 4